John Knighton

Wright Medical Group, Inc. designs, manufactures and distributes biologic products. It provides surgical solutions for the foot and ankle markets. The company was founded by Frank O. Wright and is headquartered in Memphis, TN.

The State Bar of Georgia is an organization that provides resources and support for lawyers in the state of Georgia. The organization is based in Atlanta, GA and offers programs such as committees, sections, and a lawyer assistance program. The private company's website offers a variety of services, including a member directory, legal aid resources, and virtual law museum. Additionally, they offer a comprehensive law library called Fastcase, which is a free member benefit for lawyers. The State Bar of Georgia also recommends Member Benefits, Inc. as a broker for members' health, dental, and vision insurance, as well as other approved products.

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

MicroPort Orthopedics, Inc. provides medical devices. It specializes in design, manufacture and marketing of reconstructive joint devices and related services. The company is headquartered in Arlington, TN.

KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN.

Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.